Hybridoma Selection

Screen Smarter.

Hybridoma technology enables the creation of immortalized cells that secrete monoclonal antibodies by fusing B cells with myeloma cells. Traditionally, identifying the right antibody-producing clones is time-consuming and labor-intensive.

tANCHORed displayed antigens transform this process by allowing direct, cell-based screening of secreted antibodies. By capturing only high-affinity binders at the surface, this approach enables rapid, specific isolation of productive hybridomas accelerating the selection process while reducing background and false positives.

Target the best. Skip the rest.

Select Faster.

Reference

Ivanusic D., Madela K., Burghard H., Holland G., Laue M., Bannert N. tANCHOR: a novel mammalian cell surface peptide display system. Biotechniques. 2021 Jan;70(1):21-28.

For Research Use Only